November 24, 2016 - By Hazel Jackson · 0 Comments
The stock of ASTELLAS PHARMA INCORPORATED (OTCMKTS:ALPMF) registered a decrease of 47.57% in short interest. ALPMF’s total short interest was 1.89M shares in November as published by FINRA. Its down 47.57% from 3.60 million shares, reported previously. With 200 shares average volume, it will take short sellers 9446 days to cover their ALPMF’s short positions. The stock closed at $14.87 during the last session. It is down 11.30% since April 22, 2016 and is uptrending. It has outperformed by 5.89% the S&P500.
More notable recent ASTELLAS PHARMA NPV (OTCMKTS:ALPMF) news were published by: Barrons.com which released: “Vical Looks a Lot Less Vital” on June 24, 2015, also Prnewswire.com with their article: “Royalty Pharma Statement Regarding Elan Proposal” published on March 06, 2013, Prnewswire.com published: “Clinton Group Calls on Xenoport to Hire a New CEO and Focus on Promising Drug …” on October 15, 2013. More interesting news about ASTELLAS PHARMA NPV (OTCMKTS:ALPMF) were released by: Prnewswire.com and their article: “InterMune Reports Memorandum of Understanding in Connection with Consolidated …” published on September 20, 2014 as well as Forbes.com‘s news article titled: “External Innovation: Force Multiplier For R&D” with publication date: June 26, 2015.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Hazel Jackson